Web106 rows · In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTXR / Citius Pharmaceuticals Inc. This analysis helps to understand if the insider consistently generates … WebIn-depth view of key statistics and finances for CITIUS PHARMACEUTICALS, INC. (CTXR) on MSN Money.
CTXR Citius Pharmaceuticals Inc. Analyst Estimates & Rating – …
WebMar 30, 2024 · Live In Play®. Updated: 30-Mar-23 08:33 ET. CTXR: Citius Pharmaceuticals advances efforts to spin off oncology asset, I/ONTAK, into a standalone public company (1.10) Co announced that Maxim Group LLC will serve as financial advisor to its wholly-owned subsidiary, Citius Acquisition Corp. Inc., in connection with the intended formation … WebApr 12, 2024 · Valuation is complex, but we're helping make it simple. Find out whether Citius Pharmaceuticals is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.. View the Free Analysis raytheon s75 address
Stock market today: Live updates - cnbc.com
WebCTXR Citius Pharmaceuticals Inc. Analyst Estimates & Rating – WSJ Citius Pharmaceuticals Inc. CTXR (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 04/06/23 $1.37 USD 0.06 4.58%... WebApr 13, 2024 · CTXR Stock Price Performance Analysis Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded an increase of 98.73%. Web18 hours ago · View Citius Pharmaceuticals, Inc CTXR investment & stock information. Get the latest Citius Pharmaceuticals, Inc CTXR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. simply mac deals